乳腺癌:多b值扩散加权栖息成像预测新辅助化疗后病理完全缓解
这项前瞻性研究纳入143例II-III期乳腺癌女性,在新辅助化疗前进行3-T多b值扩散加权成像,按100例训练集和43例测试集建模,比较全肿瘤放射组学、扩散加权栖息成像、常规MRI特征及联合模型预测病理完全缓解的效能,栖息成像联合常规MRI特征模型在测试集AUC达0.824。
要点
- 多b值扩散加权栖息成像模型联合常规MRI特征在测试集预测病理完全缓解AUC为0.824。
- 栖息成像模型与全肿瘤放射组学模型AUC差异无统计学意义(P=0.182)。
- 栖息成像联合常规MRI特征模型与单独栖息成像模型AUC差异无统计学意义(P=0.113)。
核心结论
- 所开发的栖息模型结合一阶特征与常规MRI特征,在新辅助化疗前可准确预测病理完全缓解,可能有助于乳腺癌个体化治疗决策。
研究设计与样本
- 前瞻性研究,纳入143例II-III期乳腺癌女性,新辅助化疗前行3-T多b值扩散加权成像,分为训练集100例(其中36例病理完全缓解)和测试集43例(其中16例病理完全缓解),基于训练集构建预测模型。
诊断标准与关键数值
- 训练集中预测病理完全缓解的AUC:全肿瘤放射组学模型0.733、扩散加权栖息成像模型0.722、常规MRI特征模型0.705、栖息成像联合常规MRI特征模型0.756;测试集中对应AUC分别为0.625、0.801、0.700、0.824;DeLong检验显示全肿瘤放射组学模型与栖息成像模型差异无统计学意义(P=0.182),栖息成像模型与栖息成像联合常规MRI特征模型差异无统计学意义(P=0.113)。
临床应用与阅片要点
- 作者认为该栖息模型在新辅助化疗前可准确预测病理完全缓解,可能有助于乳腺癌个体化治疗决策。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: The aim of this study was to ascertain whether the utilization of multiple b-value diffusion-weighted habitat imaging, a technique that depicts tumor heterogeneity, could aid in identifying breast cancer patients who would derive substantial benefit from neoadjuvant chemotherapy (NAC).
MATERIALS AND METHODS: This prospective study enrolled 143 women (II-III breast cancer), who underwent multi-b-value diffusion-weighted imaging (DWI) in 3-T magnetic resonance (MR) before NAC. The patient cohort was partitioned into a training set (consisting of 100 patients, of which 36 demonstrated a pathologic complete response [pCR]) and a test set (featuring 43 patients, 16 of whom exhibited pCR). Utilizing the training set, predictive models for pCR, were constructed using different parameters: whole-tumor radiomics (ModelWH), diffusion-weighted habitat-imaging (ModelHabitats), conventional MRI features (ModelCF), along with combined models ModelHabitats+CF. The performance of these models was assessed based on the area under the receiver operating characteristic curve (AUC) and calibration slope.
RESULTS: In the prediction of pCR, ModelWH, ModelHabitats, ModelCF, and ModelHabitats+CF achieved AUCs of 0.733, 0.722, 0.705, and 0.756 respectively, within the training set. These scores corresponded to AUCs of 0.625, 0.801, 0.700, and 0.824 respectively in the test set. The DeLong test revealed no significant difference between ModelWH and ModelHabitats (P = 0.182), between ModelHabitats and ModelHabitats+CF (P = 0.113).
CONCLUSION: The habitat model we developed, incorporating first-order features along with conventional MRI features, has demonstrated accurate predication of pCR prior to NAC. This model holds the potential to augment decision-making processes in personalized treatment strategies for breast cancer.
引用
- Xu C, Wang Z, Wang A, et al. Breast Cancer: Multi-b-Value Diffusion Weighted Habitat Imaging in Predicting Pathologic Complete Response to Neoadjuvant Chemotherapy. Acad Radiol. 2024. PMID: 38890032. doi:10.1016/j.acra.2024.06.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。